Cargando…

Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13

Cannabidiol, a compound of Cannabis sativa, has been proposed as an alternative treatment of schizophrenia. Preclinical and clinical data have suggested that cannabidiol shares more similarity with atypical antipsychotics than typical, both of which are customarily used to manage schizophrenia sympt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falvella, Ana Caroline Brambilla, Smith, Bradley Joseph, Silva-Costa, Licia C., Valença, Aline G. F., Crunfli, Fernanda, Zuardi, Antonio W., Hallak, Jaime E., Crippa, José A., de Almeida, Valéria, Martins-de-Souza, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193732/ https://www.ncbi.nlm.nih.gov/pubmed/34122009 http://dx.doi.org/10.3389/fnmol.2021.673144

Ejemplares similares

Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
por: Falvella, Ana Caroline Brambilla, et al.
Publicado: (2021)

17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018)

Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
por: Crippa, José A. S., et al.
Publicado: (2016)

Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia
por: Gouvêa-Junqueira, Danielle, et al.
Publicado: (2020)

Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
por: Breuer, Aviva, et al.
Publicado: (2016)

Correction: Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
por: Breuer, Aviva, et al.
Publicado: (2016)

Reappraisal of Human HOG and MO3.13 Cell Lines as a Model to Study Oligodendrocyte Functioning
por: De Kleijn, Kim M. A., et al.
Publicado: (2019)

F198. EFFECTS OF CANNABINOIDS ON A HUMAN OLIGODENDROCYTE CULTURE: IMPLICATIONS FOR SCHIZOPHRENIA
por: Almeida, Valéria, et al.
Publicado: (2018)

Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
por: de Meneses-Gaya, Carolina, et al.
Publicado: (2020)

Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination
por: Zirngibl, Martin, et al.
Publicado: (2022)

The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
por: Bolsoni, Lívia Maria, et al.
Publicado: (2022)

Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma
por: Vuolo, Francieli, et al.
Publicado: (2015)

Evaluation of the role of the cannabidiol system in an animal model of ischemia/reperfusion kidney injury
por: Soares, Rodrigo Zon, et al.
Publicado: (2015)

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
por: Linares, Ila M. P., et al.
Publicado: (2018)

Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy
por: Peres, Fernanda F., et al.
Publicado: (2016)

Ubiquitin–proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia
por: Seabra, Gabriela, et al.
Publicado: (2020)

Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload
por: da Silva, Vanessa Kappel, et al.
Publicado: (2018)

Biological bases for a possible effect of cannabidiol in Parkinson’s disease
por: Ferreira-Junior, Nilson C., et al.
Publicado: (2019)

EBI2 Is Temporarily Upregulated in MO3.13 Oligodendrocytes during Maturation and Regulates Remyelination in the Organotypic Cerebellar Slice Model
por: Velasco-Estevez, Maria, et al.
Publicado: (2021)

RNA-Seq Transcriptome Analysis of Differentiated Human Oligodendrocytic MO3.13 Cells Shows Upregulation of Genes Involved in Myogenesis
por: Głowacka, Aleksandra, et al.
Publicado: (2022)

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
por: Zuardi, Antonio W., et al.
Publicado: (2017)

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans
por: Nahler, Gerhard, et al.
Publicado: (2017)

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
por: Loss, Cássio Morais, et al.
Publicado: (2021)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
por: Crippa, José A., et al.
Publicado: (2018)

Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model
por: Callejas, G.H., et al.
Publicado: (2018)

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)
por: Souza, José Diogo R., et al.
Publicado: (2022)

Systemic Chronic Treatment with Cannabidiol in Carioca High- and Low-Conditioned Freezing Rats in the Neuropathic Pain Model: Evaluation of Pain Sensitivity
por: Macêdo-Souza, Carolina, et al.
Publicado: (2023)

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
por: Peres, Fernanda F., et al.
Publicado: (2018)

13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
por: Guimaraes, Francisco, et al.
Publicado: (2018)

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
por: Peres, Fernanda F., et al.
Publicado: (2016)

Cannabidiol induces autophagy via ERK1/2 activation in neural cells
por: Vrechi, Talita A. M., et al.
Publicado: (2021)

Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
por: Genaro, Karina, et al.
Publicado: (2017)

Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
por: Souza, José Diogo S., et al.
Publicado: (2022)

Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
por: Crippa, José A., et al.
Publicado: (2021)

Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy
por: Do Val-da Silva, Raquel A., et al.
Publicado: (2017)

Gas6 Increases Myelination by Oligodendrocytes and Its Deficiency Delays Recovery following Cuprizone-Induced Demyelination
por: Binder, Michele D., et al.
Publicado: (2011)

Brain-Derived Neurotrophic Factor Deficiency Restricts Proliferation of Oligodendrocyte Progenitors Following Cuprizone-Induced Demyelination
por: Tsiperson, Vladislav, et al.
Publicado: (2015)

Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
por: Fabris, Débora, et al.
Publicado: (2022)

Marijuana, feijoada and the debate on drug legalization
por: Crippa, José A. S., et al.
Publicado: (2013)

Behavioral and Neurobiological Changes in C57BL/6 Mouse Exposed to Cuprizone: Effects of Antipsychotics
por: Xu, Haiyun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nommbt55t9ca8hm66iibi33on6